49
Views
20
CrossRef citations to date
0
Altmetric
Original Research

RETRACTED ARTICLE: Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells

, , &
Pages 8153-8164 | Published online: 29 Nov 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Aprameya Prasad, Mohamed Mofreh Bakr & Aliaa N. ElMeshad. (2024) Surface-functionalised polymeric nanoparticles for breast cancer treatment: processes and advances. Journal of Drug Targeting 0:0, pages 1-15.
Read now
Roshan Katekar, Pragati Singh, Richa Garg, Saurabh Verma & Jiaur R. Gayen. (2022) Emerging nanotechnology based combination therapies of taxanes for multiple drug-resistant cancers. Pharmaceutical Development and Technology 27:1, pages 95-107.
Read now
Stefania Biffi, Rebecca Voltan, Barbara Bortot, Giorgio Zauli & Paola Secchiero. (2019) Actively targeted nanocarriers for drug delivery to cancer cells. Expert Opinion on Drug Delivery 16:5, pages 481-496.
Read now

Articles from other publishers (16)

Nima Beheshtizadeh, Zahra Amiri, Seyedeh Zoha Tabatabaei, Amir Abbas Seraji, Maliheh Gharibshahian, Akram Nadi, Morvarid Saeinasab, Farshid Sefat & Hanieh Kolahi Azar. (2024) Boosting antitumor efficacy using docetaxel-loaded nanoplatforms: from cancer therapy to regenerative medicine approaches. Journal of Translational Medicine 22:1.
Crossref
Salik Abdullah, Shreya Mukherjee, Shweta & Biplab Debnath. (2024) The prevention of multi-drug resistance in cancers through the application of nanotechnology-based targeted delivery systems for combination therapies involving traditional Chinese medicine. Pharmacological Research - Modern Chinese Medicine 10, pages 100386.
Crossref
Lai Wei, Xiangdong He, Xinyue Shang, Martha Kandawa-Shultz, Guoqiang Shao & Yihong Wang. (2023) Biotin-modified cyclometalated iridium-based photosensitizers as mitochondria-targeted theranostic agents for tumor photodynamic therapy in vitro and in vivo. Dyes and Pigments 219, pages 111641.
Crossref
Joabe Lima Araújo, Julia Augusto Vieira, Mayla dos Santos Silva, Alan Kelbis Oliveira Lima, Glecia Virgolino da Silva Luz, Marcella Lemos Brettas Carneiro & Ricardo Bentes Azevedo. (2023) Benefits of using polymeric nanoparticles in breast cancer treatment: a systematic review. 3 Biotech 13:11.
Crossref
Sahar A. Helmy, Saif El-Mofty, Amal M. El Gayar, Ibrahim M. El-Sherbiny & Yousra M. El-Far. (2022) Novel doxorubicin / folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: In-vivo superiority over standard chemotherapeutic regimen for breast cancer treatment. Biomedicine & Pharmacotherapy 145, pages 112376.
Crossref
Gamze Varan, Cem Varan, Nazlı Erdoğar & Erem Bilensoy. 2022. Targeted Nanomedicine for Breast Cancer Therapy. Targeted Nanomedicine for Breast Cancer Therapy 153 169 .
Ali Sartaj, Zufika Qamar, Farheen Fatima Qizilbash, Annu, Shadab Md, Nabil A. Alhakamy, Sanjula Baboota & Javed Ali. (2021) Polymeric Nanoparticles: Exploring the Current Drug Development and Therapeutic Insight of Breast Cancer Treatment and Recommendations. Polymers 13:24, pages 4400.
Crossref
Bowen Tan, Quan Tang, Yongjin Zhong, Yali Wei, Linfeng He, Yanting Wu, Jiabao Wu & Jinfeng Liao. (2021) Biomaterial-based strategies for maxillofacial tumour therapy and bone defect regeneration. International Journal of Oral Science 13:1.
Crossref
Ahmed A. H. Abdellatif & Abdullah Fahad Alsowinea. (2021) Approved and marketed nanoparticles for disease targeting and applications in COVID-19. Nanotechnology Reviews 10:1, pages 1941-1977.
Crossref
Muhammad Afzal, Ameeduzzafar, Khalid Saad Alharbi, Nabil K Alruwaili, Fahad A. Al-Abassi, Abdulrahman Al Labeed Al-Malki, Imran Kazmi, Vikas Kumar, Mohammad Amjad Kamal, Muhammad Shahid Nadeem, Muhammad Aslam & Firoz Anwar. (2021) Nanomedicine in treatment of breast cancer – A challenge to conventional therapy. Seminars in Cancer Biology 69, pages 279-292.
Crossref
Patrícia de Faria Lainetti, Antonio Fernando Leis-Filho, Renee Laufer-Amorim, Alexandre Battazza & Carlos Eduardo Fonseca-Alves. (2020) Mechanisms of Resistance to Chemotherapy in Breast Cancer and Possible Targets in Drug Delivery Systems. Pharmaceutics 12:12, pages 1193.
Crossref
Mohammad Imran, Sadaf Saleem, Aiswarya Chaudhuri, Javed Ali & Sanjula Baboota. (2020) Docetaxel: An update on its molecular mechanisms, therapeutic trajectory and nanotechnology in the treatment of breast, lung and prostate cancer. Journal of Drug Delivery Science and Technology 60, pages 101959.
Crossref
Saurabh Sharma, Sudeep Sudesh Pukale, Deepak K. Sahel, Devesh S. Agarwal, Manu Dalela, Sujata Mohanty, Rajeev Sakhuja, Anupama Mittal & Deepak Chitkara. (2020) Folate-Targeted Cholesterol-Grafted Lipo-Polymeric Nanoparticles for Chemotherapeutic Agent Delivery. AAPS PharmSciTech 21:7.
Crossref
Ali Sartaj, Sanjula Baboota & Javed Ali. (2020) Nanomedicine: A Promising Avenue for the Development of Effective Therapy for Breast Cancer. Current Cancer Drug Targets 20:8, pages 603-615.
Crossref
Jaidip M. Jagtap, Gayatri Sharma & Abdul K. Parchur. 2020. Nanomedicines for Breast Cancer Theranostics. Nanomedicines for Breast Cancer Theranostics 131 152 .
Shaheedul A. Sami, Noureldien H. E. Darwish, Amanda N. M. Barile & Shaker A. Mousa. (2020) Current and Future Molecular Targets for Acute Myeloid Leukemia Therapy. Current Treatment Options in Oncology 21:1.
Crossref